Publications by authors named "Toshiaki Shichijo"
Article Synopsis
- The study analyzed the effectiveness of three antipsychotic medications—aripiprazole, blonanserin, and paliperidone—over a 104-week period for patients with schizophrenia as part of the Japan Useful Medication Program for Schizophrenia (JUMPs).
- A total of 251 patients were treated, with similar treatment discontinuation rates across all medications, and positive improvements in quality of life and symptom scores were noted over time.
- The findings indicate that while treatment results were comparable, continuing with these medications can lead to improved remission rates and overall quality of life for patients.
Aim: Globally, evidence from short-term studies is insufficient for the guidelines to uniformly recommend a particular antipsychotic(s) for the maintenance treatment of schizophrenia. Therefore, long-term comprehensive evaluation of antipsychotics is required from a social rehabilitation perspective, especially for drugs that have not yet been studied. The Japan Useful Medication Program for Schizophrenia (JUMPs) is a large-scale, long-term naturalistic study to present pivotal 52-week data on the continuity of second-generation antipsychotics (SGA: aripiprazole, blonanserin, and paliperidone).
View Article and Find Full Text PDF